Correlation Between Revelation Biosciences and PsyBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on Revelation Biosciences and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and PsyBio Therapeutics.
Diversification Opportunities for Revelation Biosciences and PsyBio Therapeutics
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Revelation and PsyBio is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and PsyBio Therapeutics go up and down completely randomly.
Pair Corralation between Revelation Biosciences and PsyBio Therapeutics
Assuming the 90 days horizon Revelation Biosciences is expected to generate 1.36 times more return on investment than PsyBio Therapeutics. However, Revelation Biosciences is 1.36 times more volatile than PsyBio Therapeutics Corp. It trades about 0.08 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about 0.05 per unit of risk. If you would invest 1.90 in Revelation Biosciences on August 31, 2024 and sell it today you would lose (0.67) from holding Revelation Biosciences or give up 35.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.81% |
| Values | Daily Returns |
Revelation Biosciences vs. PsyBio Therapeutics Corp
Performance |
| Timeline |
| Revelation Biosciences |
| PsyBio Therapeutics Corp |
Revelation Biosciences and PsyBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and PsyBio Therapeutics
The main advantage of trading using opposite Revelation Biosciences and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.| Revelation Biosciences vs. Cue Biopharma | Revelation Biosciences vs. Eliem Therapeutics | Revelation Biosciences vs. Inhibrx | Revelation Biosciences vs. Molecular Partners AG |
| PsyBio Therapeutics vs. Rigel Pharmaceuticals | PsyBio Therapeutics vs. Geron | PsyBio Therapeutics vs. Verastem | PsyBio Therapeutics vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |